Request Sample
Request Methodology
Description
Contrast Media Market size was valued at USD x billion in 2021 and expected to reach a value of USD x billion by 2028, witnessing a CAGR of x% during the forecast period 2022-2028. Contrast media are the agents used in the medical imaging techniques for improving the contrast of structures or fluids in the body to help the better image of anatomical structures. Contrast media are commonly used in the various imaging techniques such as Computerized Tomography (CT), X-ray, MRI scans, and ultrasound techniques. The most commonly used contrast media are iodine and gadolinium-containing contrast media. Increase in the prevalence of cardiovascular, neurological, cancer, and other chronic diseases, a rise in technological advancements in Contrast Media Market such as syringeless power injectors, and growing usage of MRI, CT, and echocardiogram in a diagnosis of various diseases are anticipated to fuel the contrast media market over the forecast period. Moreover, approvals of the novel contrast agents, a rise in the public-private partnership for establishing diagnostic centres, product pipeline (In May 2016, Dotarem sponsored by Guerbet is in Phase 3 clinical trials), an increase in R&D activities for developing various contrasting agents also expected to boost the contrast media market. However, the adverse effects associated with the contrast media, lower adoption in underdeveloped economies, and lack of reimbursement policies are the factors hindering the growth of contrast media market.
